Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imprime PGG + Cetuximab +/- Irinotecan in Recurrent/Progressive CRC
NCT00545545Phase 2Completed
- Sponsor
- HiberCell
- Start
- Oct 2007
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of odetiglucan in colorectal carcinoma (CRC), sponsored by HiberCell. Started Oct 2007; status: completed.
02
Drugs
odetiglucan
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT00545545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545545.